ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Bioinformatics"

  • Abstract Number: 1315 • ACR Convergence 2025

    High-resolution thermography and Artificial Intelligence to evaluate and classify Rheumatoid Arthritis

    Kale Mayor1, Joey Mercier1, Yuxi Long2, David Robinson1, Pingzhao Hu2, Hani El-Gabalawy1 and Liam O'Neil1, 1University of Manitoba, Winnipeg, MB, Canada, 2Western University, London, ON, Canada

    Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune polyarthritis that typically affects the small joints of the hands and feet. While imaging modalities such as ultrasound…
  • Abstract Number: 0845 • ACR Convergence 2025

    Machine Learning–Based Skin Transcriptome Classifier (v2.0) Links SSc Molecular Subtypes to Disease Severity and Progression

    Zhiyun Gong1, Rezvan Parvizi2, Helen Jarnagin1, Haobin Chen3, Madeline Morrisson4, Tammara Wood5, Monique Hinchcliff6, Dinesh Khanna7 and Michael Whitfield8, 1Dartmouth College, Lebanon, NH, 2Dartmouth, lebanon, NH, 3Dartmouth Collge, Lebanon, NH, 4Geisel School of Medicine at Dartmouth College, Hanover, NH, 5Dartmouth, Hanover, NH, 6Yale School of Medicine, Westport, CT, 7University of Michigan, Ann Arbor, MI, 8Geisel School of Medicine, Lebanon, NH

    Background/Purpose: Systemic Sclerosis (SSc) is a clinically and molecularly heterogeneous autoimmune disease. We identified five intrinsic molecular subtypes in SSc by applying semi-supervised machine learning…
  • Abstract Number: 0019 • ACR Convergence 2025

    Single cell characterization of the circulating immune system in Sjögren’s Syndrome

    Alejandro Gómez Gómez1, Héctor Corominas2, Rosario Garcia Vicuña3, Mercedes Freire González4, Sheila Melchor-Díaz5, Paloma Vela Casasempere6, Paula Estrada-Alarcón7, Jose Luis Tandaipan8, Monica Fernandez Castro9, Sara Maria Rojas Herrera10, Marina Rodríguez López11, Beatriz Paredes-Romero12, Santiago Muñoz13, Marta López14, Ignacio Braña15, Gema Bonilla16, Raúl Menor Almagro17, Sara Manrique-Arija18, Mª Angeles Blazquez Cañamero19, Lilian López-Núñez20, Carles Galisteo Veiga21, Juan José Alegre-Sancho22, Jose Rosas Gómez de Salazar23, Jose Javier Pérez Venegas24, Judit Font-Urgelles25, José Andrés Román Ivorra26, José Miguel Sequí-Sabater27, Rafaela Ortega-Castro28, Clara Moriano29, Guadalupe Manzano-Canabal30, Cilia Peralta-Ginés31, Javier Narváez32, Rafael Cáliz-Cáliz33, Javier Martínez-Ferrin34, Lara Sánchez Bilbao35, Belén Serrano-Benavente36, Natalia Boix- Martí37, Ares Selles-Rius38, Maribel Pérez39, Juan Cañete40, Núria Palau Balaña38, Damiana Alvarez Errico39, Yolanda Guillén41, Juan Ángel Patiño Galindo41, Antonio Julià1, Sara Marsal Barril42 and Jose Luis Andreu43, 1Vall d'Hebron Hospital Research Institute, Rheumatology Research Group, Barcelona, Spain, 2Hospital de la Santa Creu i Sant Pau, Rheumatology, Barcelona, Barcelona, Spain, 3Hospital Universitario de la Princesa, Madrid, Spain, 44 Hospital Universitario A Coruña, Rheumatology, A Coruña, La coruna, Spain, 5Hospital Universitario 12 de Octubre, Rheumatology, Madrid, Madrid, 6Hospital General Universitario Alicante, Alicante, Comunidad Valenciana, Spain, 7Hospital de San Juan Despí Moisès Broggi, Barcelona, Spain, 8Rheumatology. Hospital Universitario de la Santa Creu i Sant Pau, Barcelona, Spain, 9PUERTA DE HIERRO HOSPITAL, Madrid, Spain, 10Hospital de Mérida, Rheumatology, Badajoz, Badajoz, Spain, 11Complejo Hospitalario Universitario de Santiago, Rheumatology, Santiago de Compostela., Santiago de Compostela, Spain, 12Hospital Universitario Infanta Sofía;Universidad Europea de Madrid. Faculty of Medicine, Health and Sports. Department of Medicine; FIIB HUIS-HUHEN, San Sebastian de los Reyes, Spain, 13Hospital Universitario Infanta Sofía;Universidad Europea de Madrid. Faculty of Medicine, Health and Sports. Department of Medicine; FIIB HUIS-HUHEN, Madrid, Spain, 14Complex Hospitalari Universitari Moisés Broggi, Barcelona, Spain, 15Hospital Universitario Central de Asturias, Oviedo, Spain, 16Hospital Universitario La Paz, Rheumatology, Madrid, Madrid, Spain, 17Department of Rheumatology, Hospital de Jerez, Spain, Puerto De Santa María, Spain, 18Hospital Regional Universitario Málaga, Malaga, Spain, 19Hospital Ramon y Cajal, Madrid, Spain, 20Hospital Son Llatzer, Rheumatology, Palma de Mallorca, Palma de Mallorca, Spain, 21Hospital Parc Taulí, Rheumatology, Sabadell, Sabadell, Spain, 22Hospital Universitario Doctor Peset, Valencia, Spain, 23Hospital Marina Baixa, PALMA DE MALLORCA, Spain, 24Virgen Macarena University Hospital, Sevilla, Spain, Sevilla, Spain, 25Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 26Hospital Universitari i Politècnic La Fe, Valencia, Spain, 27Hospital Universitario La Fe (Valencia), Valencia, Spain, 28Rheumatology service/Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ Reina Sofia University Hospital/ University of Cordoba, Spain, Cordoba, Andalucia, Spain, 29Hospital León, LEON, Castilla y Leon, Spain, 30Hospital Virgen de la Concha (Zamora), Zamora, Spain, 31Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain, 32Hospital Universitario de Bellvitge, Barcelona, Spain, 33Hospital Universitario Virgen de las Nieves, Rheumatology, Granada, Granada, Spain, 34Hospital Universitario Virgen de la Arrixaca, Rheumatology, Murcia, Murcia, Spain, 35Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain, Santander, Cantabria, Spain, 36Hospital Gregorio Marañon, Madrid, Spain, 37Hospital Univetsitari Vall d'Hebron, Rheumatology Department, Barcelona, Spain, 38Rheumatology Research Group, Vall d'Hebron University Hospital, Barcelona, Spain, 39IMIDomics, Barcelona, Barcelona, Spain, 40Rheumatology Department, Hospital Clínic and IDIBAPS, Barcelona, Spain, Barcelona, Spain, 41IMIDomics, Barcelona, Spain, 42Vall Hebron Hospital Research Institute, Barcelona, Spain, 43Hospital Universitario Puerta de Hierro, Majadahonda, Spain

    Background/Purpose: Sjögren’s syndrome (SS) is a chronic autoimmune disease characterized by the infiltration of circulating immune cells into the salivary and lacrimal glands. The properties…
  • Abstract Number: 1309 • ACR Convergence 2025

    Transcriptomic biomarkers of progression from undifferentiated arthritis to rheumatoid arthritis

    Christina Printzis1, Keerthana Nagesh Prabhu2, Regina Sakalyte3, Sigita Stropuviene3 and Damini Jawaheer1, 1Northwestern University, Chicago, IL, 2Washington University in St. Louis, St Louis, MO, 3Vilnius University, Faculty of Medicine, Institute of Clinical Medicine, Clinic of Rheumatology, Orthopedics Traumatology and Reconstructive Surgery, Vilnius, Lithuania

    Background/Purpose: A broad range (6-55%) of patients classified as having undifferentiated arthritis (UA) tend to progress to rheumatoid arthritis (RA), suggesting that UA in these…
  • Abstract Number: 0808 • ACR Convergence 2025

    Spatial Transcriptomics Show Fibroblast LIF Receptor Drives Fibrosis in Systemic Sclerosis

    Mari Kamiya1, Hung Nguyen1, Miles Tran2, Ce Gao3, Sergio Poli1, Yunju Jeong4, Louis Merriam5, Jinjun Shi6, Rachel Knipe7, Katharine Black8, Lida Hariri9, Carol Feghali-Bostwick10, Rodney Infante11, Janelle Pugashetti12, Justin Oldham12, Ilya Korsunsky13, Kevin Wei14 and Edy Kim1, 1Division of Pulmonary and Critical Care Medicine, Department of Medicine (DOM), Brigham and Women's Hospital (BWH); Harvard Medical School, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Division of Rheumatology, Inflammation and Immunity, DOM, BWH; Harvard Medical School, Boston, MA, 4Division of Pulmonary and Critical Care Medicine, Department of Medicine (DOM), Brigham and Women's Hospital (BWH), Harvard Medical School, Boston, MA, United States; Department of Food and Nutrition, College of Human Ecology, Kyung Hee University, Seoul, Republic of Korea, 5Division of Pulmonary and Critical Care Medicine, Department of Medicine (DOM), Brigham and Women's Hospital (BWH), Boston, MA, 6Center for Nanomedicine and Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital (BWH); Harvard Medical School, Boston, MA, 7Division of Pulmonary and Critical Care Medicine, DOM, Massachusetts General Hospital; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital; Harvard Medical School, Boston, MA, 8Division of Pulmonary and Critical Care Medicine, DOM, Massachusetts General Hospital; Harvard Medical School, Boston, MA, 9Department of Pathology, Massachusetts General Hospital; Division of Pulmonary and Critical Care Medicine, DOM, Massachusetts General Hospital; Harvard Medical School, Boston, MA, 10Medical University of South Carolina, Charleston, SC, 11Center for Human Nutrition, Dept. of Molecular Genetics, DOM, University of Texas Southwestern, Dallas, TX, 12Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, 13Division of Rheumatology, Inflammation and Immunity, DOM, BWH; Division of Genetics, DOM, BWH; Harvard Medical School, Boston, MA, 14Brigham and Women's Hospital at Harvard Medical School, Boston, MA

    Background/Purpose: Systemic sclerosis (SSc) is an autoimmune, fibroinflammatory disease of skin and visceral organs. Current SSc therapies have limited efficacy for progressive fibrosis. Our prior…
  • Abstract Number: 2114 • ACR Convergence 2025

    Development of a Fracture Prediction Model for Patients Aging with HIV

    Evelyn Hsieh1, Terrence E. Murphy2, Baylah Tessier-Sherman3, Linda Leo-Summers3, Farah Kidwai-Khan4, Samah Fodeh5, Rixin Wang6, Barbara Gulanski3, Michael T. Yin7, Melissa Skanderson8, Cynthia Brandt9, Amy C. Justice4 and Julie Womack10, 1Section of Rheumatology, Allergy and Immunology, Yale School of Medicine / VA Connecticut Healthcare System, New Haven, CT, 2Department of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, PA, 3Department of Internal Medicine, Yale School of Medicine, New Haven, CT, 4Department of Internal Medicine, Yale School of Medicine / VA Connecticut Healthcare System, New Haven, CT, 5Department of Emergency Medicine, Yale School of Medicine, New Haven, CT, 6Department of Biomedical Informatics & Data Science, Yale School of Medicine, New Haven, CT, 7Columbia University Irving Medical Center, New York, NY, 8VA Connecticut Healthcare System, West Haven, CT, 9Department of Biomedical Informatics & Data Science, Yale School of Medicine / VA Connecticut Healthcare System, New Haven, CT, 10Yale School of Nursing / VA Connecticut Healthcare System, Orange, CT

    Background/Purpose: Fragility fractures are a critical outcome for people ageing with HIV (PAH). Studies demonstrate higher prevalence, incidence, and earlier onset than for the general…
  • Abstract Number: 2666 • ACR Convergence 2025

    Rare TNFAIP3 Hypomorphic Variants are a Massively Underestimated Driver of Human Autoinflammatory Disease

    Danica Lee1, Urekha Karri2, Yiming Luo3, Kader Cetin Gedik4, Manuel Carpio Tumba5, Prabal Chhibbar6, Priyamvada Roy6, Guido Falduto7, Jishnu Das5 and Daniella Schwartz5, 1University of Pittsburgh School of Medicine, Pittsburgh, PA, 2School of public health, Pittsburgh, PA, 3Columbia University, New York, NY, 4UPMC Children's Hospital of Pittsburgh/University of Pittsburgh, Pittsburgh, PA, 5University of Pittsburgh, Pittsburgh, PA, 6University of Pittsburgh School of Medicine, Pittsburgh, 7University of Pittsburgh Medical Center, Pittsburgh, PA

    Background/Purpose: TNFAIP3 encodes the ubiquitin editing enzyme A20, which inhibits multiple proinflammatory signaling pathways. Heterozygous germline mutations in TNFAIP3 cause the autoinflammatory disease Haploinsufficiency of…
  • Abstract Number: 1303 • ACR Convergence 2025

    Impact of Fruits and Vegetables Intake on Immune-mediated Inflammatory Diseases:a Two-sample Mendelian Randomization Study

    Xuemei Tang, Yuting Zhou, Yuxiao Chen, Xinglin Wu and Qiang Luo, Department of Rheumatology and Immunology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, China, Chongqing, China (People's Republic)

    Background/Purpose: A balanced diet can prevent diseases and promote physical and mental health. Accumulating evidence shows that fruits and vegetables (F&Vs) intake is associated with…
  • Abstract Number: 0797 • ACR Convergence 2025

    Spatial transcriptomics identifies density-sensing fibroblasts in synovial lining

    Sonia Presti1, Kseniia Anufrieva2, Ce Gao3, Sean Prell2, Philip Blazar2, Jeffrey Lange2, Morgan Jones2, Mihir Wechalekar4, Michael Brenner2, Ilya Korsunsky5, Shideh Kazerounian2 and Kevin Wei6, 1Standford University, Stanford, 2Mass General Brigham, Boston, 3Division of Rheumatology, Inflammation and Immunity, DOM, BWH; Harvard Medical School, Boston, MA, 4Flinders Medical Centre, Adelaide, Australia, 5Division of Rheumatology, Inflammation and Immunity, DOM, BWH; Division of Genetics, DOM, BWH; Harvard Medical School, Boston, MA, 6Brigham and Women's Hospital at Harvard Medical School, Boston, MA

    Background/Purpose: The synovial lining is crucial for joint homeostasis, forming a barrier and producing lubricants through specialized fibroblasts. These fibroblasts differ from sublining fibroblasts, which…
  • Abstract Number: 2639 • ACR Convergence 2025

    Gut Microbiome Signatures Forecast Clinical Response to Methotrexate in Treatment-Naïve Early Rheumatoid Arthritis

    VINOD GUPTA1, Adam Koller1, Benjamin Hur1, Marissa Bailey1, Kara Delger2, Elena myasoedova1, Vanessa Kronzer1, John Davis1 and Jaeyun Sung1, 1Mayo Clinic, ROCHESTER, MN, 2Mayo Clinic, St Charles, MN

    Background/Purpose: Oral methotrexate (MTX) is the cornerstone treatment for newly diagnosed rheumatoid arthritis (RA), yet up to 50% of patients do not respond adequately. Early…
  • Abstract Number: 1210 • ACR Convergence 2025

    Artificial Intelligence-Based Capillaroscopy and Laboratory Biomarkers to Predict Disease Activity in Idiopathic Inflammatory Myopathies: Preliminary Data from the CapIAMI Cohort

    Gema María Lledó Ibáñez1, Jorge Álvarez-Troncoso2, Borja del Carmelo Gracia Tello3, Sergio Prieto-Gonzalez4, Elena Martínez Robles5, Diana Cristina-Varela6, Sebastián Molina-Ríos7, Luis Sáez Comet8, Eiman Soliman9, Franklin Uguña10, Miguel Antonio Mesa11, Miguel Martín Cascón12, Tânia Santiago13, Grace-Jimena Santamaría-Peñaloza14, Tsvetoslav Georgiev15, Santiago Bernal-Macias16, Begoña Marí-Alfonso17, Jesus Ballano Rodríguez-Solís18, Sally Patricia Pino Hernández19, Jacek Olas20, Juan Manuel Mosquera Angarita21, Elena García- Guijarro22, Isabel Perales Fraile23, Mayka Freire Dapena24, Iván Pérez de Pedro25, Luis Adrián Viteri Noël26 and Eduardo Ramos ibáñez27, 1Hospital Clínic de Barcelona, Barcelona, Spain, 2Hospital Universitario La Paz, Madrid, Madrid, Spain, 3Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain, 4Hospital Clinic, Barcelona, Catalonia, Spain, 5Hospital Universitario La Paz, Madrid, Spain, 6Unidad de Reumatología, Hospital General de Medellín, Medellín, Colombia, Medellín, Colombia, 7Hospital Universitario Nacional de Colombia, Bogotá, Colombia, Bogotá, Colombia, 8Hospital Universitario Miguel Servet, Zaragoza, Spain, 9Alexandria Faculty of Medicine, Alexandria, Egypt, 10Sociedad Ecuatoriana de Reumatologia, Quito, Ecuador, 11Universidad Pontificia Bolivariana, Medellin, Colombia, 12Hospital General Universitario Morales Meseguer, Murcia, Spain, 13ULS de Coimbra, Coimbra, Portugal, 14Hospital Metropolitano, Quito, Ecuador, 15Hospital St. Marina, Varna, Varna, Bulgaria, 16Hospital Universitario San Ignacio, Bogotá, Colombia, 17Hospital Universitario Parc Taulí, Barcelona, Spain, 18Hospital Universitario del Henares, Alcalá de Henares, Madrid, Spain, 19Asoreuma, Care for Kids, Bogota, Distrito Capital de Bogota, Colombia, 20MCRIiR, Szpital Specjalistyczny im. J. Dietla w Krakowie, Cracow, Poland, 21Hospital Sant Joan de Déu, Barcelona, Spain, 22Hospital Universitario Infanta Cristina, Madrid, Spain, 23Hospital Universitario Infanta Sofía, Madrid, Spain, 24Hospital Clínico Universitario de Santiago de Compostela, La Coruña, Spain, 25Hospital Regional Universitario de Málaga, Málaga, Spain, 26Hospital Universitario Ramón y Cajal, Madrid, Spain, 27Capillary.io, Zaragoza, Aragon, Spain

    Background/Purpose: Nailfold videocapillaroscopy (NVC) is a valuable non-invasive tool for assessing microvascular damage in autoimmune diseases. However, its application in idiopathic inflammatory myopathies (IIM) remains…
  • Abstract Number: 0504 • ACR Convergence 2025

    Spatial profiling of gene signatures in synovial tissue informs treatment strategy for Rheumatoid Arthritis

    Vincent Wong1, Katie Lowe2, Annabelle Small3, Christopher Altmann3, Susanna Proudman4, Malcolm Smith2, Wittaya Suwakulsiri5, Ranjeny Thomas5, Chung Hoow Kok6 and Mihir Wechalekar7, 1College of Medicine and Public Health, Bedford Park, South Australia, Australia, 2Flinders University, Adelaide, South Australia, Australia, 3Flinders University, Bedford Park, South Australia, Australia, 4The University of Adelaide, Adelaide, Victoria, Australia, 5Frazer Institute, University of Queensland, Brisbane, Queensland, Australia, 6Centre for Cancer Biology, and Clinical Health Sciences, University of South Australia, Adelaide, South Australia, Australia, 7Flinders Medical Centre and Flinders University, Bedford Park, South Australia, Australia

    Background/Purpose: Rheumatoid arthritis (RA) shows heterogeneous therapeutic responses that may reflect diversity within synovial tissue (ST). We aimed to identify gene signatures that predict Adalimumab…
  • Abstract Number: 2601 • ACR Convergence 2025

    Characterisation of immunometabolic reprogramming at the single cell level in patients with systemic lupus erythematosus and preclinical autoimmunity

    Antonios Psarras1, Sinibaldo Arocha2, Liezel Tamon2, David Ahern2, Md Yuzaiful Md Yusof3, Ed Vital4 and Alexander Clarke5, 1University of Oxford, Oxford, England, United Kingdom, 2University of Oxford, Oxford, United Kingdom, 3University of Leeds, Leeds, United Kingdom, 4University of Leeds, Leeds, England, United Kingdom, 5Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom

    Background/Purpose: Systemic lupus erythematosus (SLE) is characterised by innate immune activation and autoantibodies against nucleic self-antigens. The metabolic state of immune cells is emerging as…
  • Abstract Number: 1168 • ACR Convergence 2025

    Interstitial Lung Disease-Associated Antibody Testing and Positivity Rates in Systemic Autoimmune Rheumatic Diseases from a National Reference Laboratory

    Karis Lee1, Min Kyung Lee2 and Stanley Naides3, 1Labcorp, Orlando, FL, 2Labcorp, Durham, NC, 3Labcorp, Dana Point, CA

    Background/Purpose: Interstitial lung disease (ILD) is frequent in systemic autoimmune rheumatic diseases (SARDs) and is associated with poor prognosis. The prevalence of ILD is approximately…
  • Abstract Number: 0329 • ACR Convergence 2025

    Machine Learning-Based Model to Predict Rapid Structural Progression in Knee Osteoarthritis

    Maria Fernanda Gonzalez Hernandez1, Ignacio rego Pérez2, Isabel Rodríguez Valle3, Jorge Vázquez García4, Vanesa Balboa5, Sara Relaño Fernández4, María C. de Andrés6, Lucía Lourido7, Valentina Calamia7, Rocio Paz González4, Patricia Quaranta7, Patricia Fernández-Puente4, Nicola Veronese8, Cristina Ruiz-Romero9, Natividad Oreiro10 and francisco J Blanco11, 1Instituto de Investigacion Biomedica de A Coruna (INIBIC), A coruña, Galicia, Spain, 2Department of Rheumatology, Rheumatology Research Group (GIR) Biomedical Re-search Institute (INIBIC), A Coruña, Spain, 3Instituto de Investigacion Biomedica de A Coruna (INIBIC), Coruña, Galicia, Spain, 4Instituto de Investigacion Biomedica de A Coruna (INIBIC), coruña, Spain, 5Grupo de Investigación de Reumatología (GIR). Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, coruña, Spain, 6Instituto de Investigación Biomédica de A Coruña (INIBIC), Grupo de Investigación de Reumatología (GIR), A Coruña, Spain, 7Instituto de Investigacion Biomedica de A Coruna (INIBIC), coruna, Spain, 8Geriatric Unit, Department of Internal Medicine and Geriatrics, University of Palermo, palermo, Italy, 9Department of Rheumatology, Rheumatology Research Group (GIR) Biomedical Re-search Institute (INIBIC),, A Coruña, Spain, 10CHUAC, La Coruna, Spain, 11INIBIC-University of A Coruña, A Coruña, Galicia, Spain

    Background/Purpose: Osteoarthritis (OA) is the most common chronic joint disorder, characterized by structural cartilage and bone damage that often causes pain and disability. However, the…
  • 1
  • 2
  • 3
  • …
  • 21
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology